340
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Prevalence, Risk Factor and Clinical Characteristics of Venous Thrombus Embolism in Patients with Acute Exacerbation of COPD: A Prospective Multicenter Study

ORCID Icon, , , , , ORCID Icon, ORCID Icon, , & show all
Pages 907-917 | Received 04 Mar 2023, Accepted 29 Apr 2023, Published online: 18 May 2023

References

  • Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: 2021 report. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf. Accessed January 10, 2021.
  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/s0140-6736(12)61728-0
  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Arch Bronconeumol. 2017;53(3):128–149. doi:10.1016/j.arbres.2017.02.001
  • Borvik T, Braekkan SK, Enga K, et al. COPD and risk of venous thromboembolism and mortality in a general population. Eur Respir J. 2016;47(2):473–481. doi:10.1183/13993003.00402-2015
  • Keramidas G, Gourgoulianis KI, Kotsiou OS. Venous thromboembolic disease in chronic inflammatory lung diseases: knowns and unknowns. J Clin Med. 2021;10(10):10. doi:10.3390/jcm10102061
  • Dong F, Huang K, Ren X, et al. Factors associated with inpatient length of stay among hospitalised patients with chronic obstructive pulmonary disease, China, 2016–2017: a retrospective study. BMJ Open. 2021;11:2. doi:10.1136/bmjopen-2020-040560
  • Aleva FE, Voets LWLM, Simons SO, de Mast Q, van der Ven AJAM, Heijdra YF. Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD a systematic review and meta-analysis. Chest. 2017;151(3):544–554. doi:10.1016/j.chest.2016.07.034
  • Sato R, Hasegawa D, Nishida K, Takahashi K, Schleicher M, Chaisson N. Prevalence of pulmonary embolism in patients with acute exacerbations of COPD: a systematic review and meta-analysis. Am J Emerg Med. 2021;50:606–617. doi:10.1016/j.ajem.2021.09.041
  • Wells PS, Owen C, Doucette S, Fergusson D, Tran H. Does this patient have deep vein thrombosis? JAMA. 2006;2:199–207. doi:10.1001/jama.295.2.199
  • Klok FA, Mos ICM, Nijkeuter M, et al. Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. Arch Intern Med. 2008;168(19):2131–2136. doi:10.1001/archinte.168.19.2131
  • Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism. N Engl J Med. 2006;354(22):2317–2327. doi:10.1056/NEJMoa052367
  • Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603. doi:10.1093/eurheartj/ehz405
  • Couturaud F, Bertoletti L, Pastre J, et al. Prevalence of pulmonary embolism among patients with COPD hospitalized with acutely worsening respiratory symptoms. JAMA. 2021;325(1):59–68. doi:10.1001/jama.2020.23567
  • Dentali F, Pomero F, Di Micco P, et al. Prevalence and risk factors for pulmonary embolism in patients with suspected acute exacerbation of COPD: a multi-center study. Eur J Intern Med. 2020;80:54–59. doi:10.1016/j.ejim.2020.05.006
  • Hassen MF, Tilouche N, Jaoued O, Elatrous S. Incidence and impact of pulmonary embolism during severe COPD exacerbation. Respir Care. 2019;64(12):1531–1536. doi:10.4187/respcare.06661
  • Pang H, Wang L, Liu J, et al. The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease. Clin Respir J. 2018;12(11):2573–2580. doi:10.1111/crj.12959
  • Bahloul M, Chaari A, Tounsi A, et al. Incidence and impact outcome of pulmonary embolism in critically ill patients with severe exacerbation of chronic obstructive pulmonary diseases. Clin Respir J. 2015;9(3):270–277. doi:10.1111/crj.12131
  • Akpinar EE, Hosgun D, Akpinar S, Atac GK, Doganay B, Gulhan M. Incidence of pulmonary embolism during COPD exacerbation. J Bras Pneumol. 2014;40(1):38–45. doi:10.1590/s1806-37132014000100006
  • Choi K-J, Cha S-I, Shin K-M, et al. Prevalence and predictors of pulmonary embolism in Korean patients with exacerbation of chronic obstructive pulmonary disease. Respiration. 2013;85(3):203–209. doi:10.1159/000335904
  • Ristic L, Rancic M, Radovic M, Ciric Z, Kutlesic Kurtovic D. Pulmonary embolism in chronic hypoxemic patients with and without secondary polycythemia--analysis of risk factors in prospective clinical study. Med Glas. 2013;10(2):258–265.
  • Tillie-Leblond I, Marquette CH, Perez T, et al. Pulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factors. Ann Intern Med. 2006;144(6):390–396. doi:10.7326/0003-4819-144-6-200603210-00005
  • Gunen H, Gulbas G, In E, Yetkin O, Hacievliyagil SS. Venous thromboemboli and exacerbations of COPD. Eur Respir J. 2010;35(6):1243–1248. doi:10.1183/09031936.00120909
  • Schneider C, Bothner U, Jick SS, Meier CR. Chronic obstructive pulmonary disease and the risk of cardiovascular diseases. Eur J Epidemiol. 2010;25(4):253–260. doi:10.1007/s10654-010-9435-7
  • Fu X, Zhong Y, Xu W, et al. The prevalence and clinical features of pulmonary embolism in patients with AE-COPD: a meta-analysis and systematic review. PLoS One. 2021;16:9. doi:10.1371/journal.pone.0256480
  • Girard P, Sanchez O, Leroyer C, et al. Deep venous thrombosis in patients with acute pulmonary embolism - prevalence, risk factors, and clinical significance. Chest. 2005;128(3):1593–1600. doi:10.1378/chest.128.3.1593
  • Fletcher-Sanfeliu D, Redon J, Garcia-Granero A, et al. Pulmonary thrombosis in situ': risk factors, clinic characteristics and long-term evolution. Blood Coagulation Fibrinolysis. 2020;31(7):469–475. doi:10.1097/mbc.0000000000000949
  • Davoodi M, Rezvankhah B, Gohari Moghadam K, Hashemi Taheri AP. The prevalence and predicting factors of pulmonary thromboembolism in patients with exacerbated chronic obstructive pulmonary disease. Adv Respir Med. 2018;86(4):168–171. doi:10.5603/ARM.a2018.0025
  • Cao Y-Q, Dong L-X, Cao J. Pulmonary embolism in patients with acute exacerbation of chronic obstructive pulmonary disease. Chin Med J. 2018;131(14):1732–1737. doi:10.4103/0366-6999.235865
  • Wang T-S, Su X-L, Mao Y-M, Sun Y-X. Pulmonary embolism in patients with chronic obstructive pulmonary disease and exacerbations of unknown origin. Asian Biomed. 2013;7(4):529–535. doi:10.5372/1905-7415.0704.208
  • Rutschmann OT, Cornuz J, Poletti P-A, et al. Should pulmonary embolism be suspected in exacerbation of chronic obstructive pulmonary disease? Thorax. 2007;62(2):121–125. doi:10.1136/thx.2006.065557
  • Shapira-Rootman M, Beckerman M, Soimu U, Nachtigal A, Zeina A-R. The prevalence of pulmonary embolism among patients suffering from acute exacerbations of chronic obstructive pulmonary disease. Emerg Radiol. 2015;22(3):257–260. doi:10.1007/s10140-014-1280-7